ClinicalTrials.gg
CompletedNCT00580528Updated Sep 1, 2023

Reducing Blood Pressure in Prehypertensive Older Rural Women Also Known as Wellness for Women: DASHing Toward Health

An interventional study of Tailored Internet Newsletters and Tailored print newsletters delivered via mail in Pre-Hypertension, sponsored by University of Nebraska. Completed at 1 site in United States. Open to female participants aged 40 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-01.

Sponsored by University of Nebraska · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Aug 2006, registered Dec 2007).
Phase
Not applicable
Study type
Interventional
Enrollment
289
Allocation
Randomized
Ages
40 Years to 69 Years
Sex
Female
01

Study summary

The purpose of this study is to evaluate the effectiveness of a theory-based intervention tailored to constructs in the Health Promotion Model and delivered by two distance modes to achieve improvement in healthy eating and physical activity for the control of blood pressure (BP) among an underserved and vulnerable population of prehypertensive rural women aged 50 to 69.

Read the detailed description

Hypertension (HTN), a major health problem in the US, is the most prevalent modifiable risk factor for cardio-vascular disease (CVD), the leading killer of women. The incidence of HTN in women increases markedly after menopause, equaling or exceeding that in men. The prehypertension category of blood pressure (BP) -- systolic BP of 120-139 mm Hg or diastolic BP of 80-89 mm Hg -- designates individuals at high risk of developing HTN. Prehypertensive women are not candidates for drug therapy, but for lifestyle modifications to prevent progression to HTN and CVD. Recommended lifestyle modifications include adoption of the Dietary Approaches to Stop Hypertension (DASH) diet that is high in fruits, vegetables and low fat dairy products; dietary sodium reduction; regular endurance physical activity supplemented by resistance exercise; and weight reduction by those who are overweight or obese. A few studies of face-to-face individual and/or group interventions have demonstrated that these lifestyle modifications could lower BP over 6 months in pre-hypertensive individuals. There remains a need to develop distance delivery methods to target rural women with similar behavioral interventions to lower BP. This competitive renewal application will build upon our current work in which we demonstrated that computer-generated print (mailed) newsletters tailored to constructs in the Health Promotion Model (HPM) resulted in significant and clinically important changes in behavioral and biomarkers of healthy eating and physical activity in a general population of rural midlife/older women. The proposed randomized controlled trial will evaluate Internet versus mailed print delivery methods for delivering theory-based tailored newsletters to encourage lifestyle change for BP reduction. A sample of 275 prehypertensive rural women aged 50-69 will be randomly assigned 2:2:1 to receive a) tailored messages delivered via the Internet and brief telephone counseling, b) tailored print newsletters delivered via mail and brief telephone counseling, or c) initial standard advice only. Results of this study may lead to expanded access to lifestyle guidance via the Internet by other populations.

02

Conditions studied

  • Pre-Hypertension

Browse trials for

03

In context

Prehypertension

158 studies on the registry are indexed under Prehypertension; 21 are open to participants now.

This study's enrollment of 289 is above the median of 66 across 138 interventional studies indexed under Prehypertension.

Browse Prehypertension studies →

Lead sponsor

University of Nebraska is the lead sponsor of 496 studies on the registry; 67 are open to participants now.

Of its 83 completed or terminated interventional studies of FDA-regulated products, 53 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 69 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women aged 50-69
  • BP in prehypertensive range (SBP 120-139 or DBP 80-89 mm Hg)
  • speak and read English (including ESL)
  • able to communicate over the telephone
  • able to use a computer with minimal assistance
  • have access to the Internet
  • have access to a VCR or DVD player
  • able to walk without an assistive device
  • answer 'no' to all questions on the Physical Activity Readiness Questionnaire (PAR-Q) or obtain clearance from their physician

Exclusion criteria

Exclusion Criteria:

  • in the maintenance stage of readiness for change in both components of physical activity and all three components of healthy eating behaviors
  • more than 14 alcoholic drinks per week
  • taking anti-hypertensive medication, including diuretics
  • taking cortisone
  • currently enrolled in a formal program of cardiac rehabilitation or undergoing physical rehabilitation
  • unable to walk one mile continuously without stopping to rest
  • current cancer treatment
  • other physical or medical restrictions that would preclude following the JNC7 recommendations for moderate physical activity and healthy eating.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
289 participants (actual)

Study arms

  • Experimental
    1 Tailored internet newsletters

    Tailored newsletters delivered via the Internet with content for improving eating and activity to reduce blood pressure.

    Behavioral: Tailored Internet Newsletters

  • Experimental
    2 Tailored print newsletters

    Tailored print newsletters delivered via the mail with content for improving eating and activity to reduce blood pressure.

    Behavioral: Tailored print newsletters delivered via mail

  • No intervention
    3 No newsletters

    Participants receive no newsletters

Interventions

  • BehavioralTailored Internet Newsletters

    Tailored newsletters delivered via the Internet with content for improving eating and activity to reduce blood pressure

  • BehavioralTailored print newsletters delivered via mail

    Tailored Newsletters with content to improve eating and activity to reduce blood pressure

06

What researchers measure

Primary outcomes

  1. Blood pressure

    Blood pressure with the criterion of normotensive status

    Time frame: 24 months

Secondary outcomes

  1. Daily moderate physical activity and strength enhancing/maintenance activities

    Engaging regularly, preferably daily, in sustained or intermittent (10 minute bouts) moderate physical activity for at least 30 minutes per day and performing physical activities that enhance and maintain muscular strength at least twice a week.

    Time frame: 24 months

  2. DASH diet goals

    Meeting the DASH diet's average daily goals of no more than 27% of calories from fat, less than 7% of calories from saturated fat 4-5 servings of fruits, 4-5 servings of vegetables, 2-3 servings of low fat dairy products and no more than 2400 mg. sodium.

    Time frame: 24 months

07

Study locations

1 site
  • University of Nebraska Medical Center
    Omaha, Nebraska 68198, United States
08

References and documents

Publications

  • Hageman PA, Pullen CH, Hertzog M, Boeckner LS. Effectiveness of tailored lifestyle interventions, using web-based and print-mail, for reducing blood pressure among rural women with prehypertension: main results of the Wellness for Women: DASHing towards Health clinical trial. Int J Behav Nutr Phys Act. 2014 Dec 6;11:148. doi: 10.1186/s12966-014-0148-2. PubMed 25480461 ↗
  • Hageman PA, Pullen CH, Hertzog M, Boeckner LS, Walker SN. Associations of cardiorespiratory fitness and fatness with metabolic syndrome in rural women with prehypertension. J Obes. 2012;2012:618728. doi: 10.1155/2012/618728. Epub 2012 Nov 25. Erratum In: J Obes. 2014;2014:412430. PubMed 23227315 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2006 to primary completion in May 2010, 45 months.

Of 56 non-industry interventional studies with no phase under Prehypertension, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 37. This study's 45 months is above that.

Counting every sponsor, half of 60 studies reached it within 20 months; a quarter within 11 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2007
First posted
Dec 24, 2007
StartActual
Aug 1, 2006
Primary completionActual
May 1, 2010
CompletionActual
May 1, 2011
Last update
Sep 1, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00580528
Responsible party
Sponsor
First posted
Dec 24, 2007
Start date
Aug 1, 2006
Primary completion
May 1, 2010
Completion
May 1, 2011
Last update
Sep 1, 2023

Study contacts

Carol H Pullen, EdD
principal investigator · University of Nebraska

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion